Bahrain has approved the Sinopharm COVID-19 vaccine for children aged between 3 and 11 years, from October 27.
The country's National Medical Taskforce for Combatting the Coronavirus said the decision was taken following a thorough review of all health and safety recommendations.
It also added that the Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11.
The Taskforce stressed that it is important that eligible children get vaccinated to protect themselves, their families, and public health.
Parents can register their children through the Ministry of Health's website or through the BeAware application.
Registration requires the consent of a legal guardian and an adult must accompany the child when receiving the vaccine.
Sinopharm vaccine approved for all children aged 3 to 11https://t.co/AwEJ2fBddb
— Bahrain News Agency (@bna_en) October 26, 2021
Ukrainian rescuers clear rubble as Kyiv mourns 30 killed in Russian attack
Monaco blast suspect is a Ukrainian woman who fled to Germany
Clinical trials begin for two potential Ebola treatments
India issues notice to Telegram, Signal on concerns over usernames, source says
Blast at Damascus cafe kills nine, wounds 20
Rebels in Indonesia's Papua kill American pilot, burn plane
Russian air strikes kill 10, injure more than 50 in Ukraine's Kyiv
Firefighters battle wildfire in southern France
